Induced Pluripotent Stem Cells Production Market Size, Trends, Analysis, and Outlook By Process (Manual iPSC Production Process, Automated iPSC Production Process), By Workflow (Reprogramming, Cell Culture, Cell Characterization / Analysis, Engineering, Others), By Product (Instruments/ Devices, Automated Platforms, Consumables & Kits, Services), By Application (Drug Development and Discovery, Regenerative Medicine, Toxicology Studies, Others), By End-User (Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, Hospitals & Clinics), by Region, Country, Segment, and Companies, 2024-2030
The global Induced Pluripotent Stem Cells Production market size is poised to register 9.22% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Induced Pluripotent Stem Cells Production market across By Process (Manual iPSC Production Process, Automated iPSC Production Process), By Workflow (Reprogramming, Cell Culture, Cell Characterization / Analysis, Engineering, Others), By Product (Instruments/ Devices, Automated Platforms, Consumables & Kits, Services), By Application (Drug Development and Discovery, Regenerative Medicine, Toxicology Studies, Others), By End-User (Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, Hospitals & Clinics).
The induced pluripotent stem cells production market is experiencing significant growth driven by the increasing demand for regenerative medicine and cell-based therapies, rising investment in stem cell research, and advancements in cellular reprogramming and differentiation techniques. In 2024 and beyond, factors such as the growing application of iPSCs in drug discovery, disease modeling, and tissue engineering, expansion of iPSC production facilities and biobanks, and rising adoption of automation and quality control measures drive market expansion. Additionally, the development of integration-free and xeno-free reprogramming methods, adoption of genome editing tools for genetic correction, and collaborations between stem cell companies and research institutions contribute to market growth.
Induced Pluripotent Stem Cells Production Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Induced Pluripotent Stem Cells Production market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Induced Pluripotent Stem Cells Production survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Induced Pluripotent Stem Cells Production industry.
Key market trends defining the global Induced Pluripotent Stem Cells Production demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Induced Pluripotent Stem Cells Production Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Induced Pluripotent Stem Cells Production industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Induced Pluripotent Stem Cells Production companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Induced Pluripotent Stem Cells Production industry
Leading Induced Pluripotent Stem Cells Production companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Induced Pluripotent Stem Cells Production companies.
Induced Pluripotent Stem Cells Production Market Study- Strategic Analysis Review
The Induced Pluripotent Stem Cells Production market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Induced Pluripotent Stem Cells Production industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Induced Pluripotent Stem Cells Production Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Induced Pluripotent Stem Cells Production Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Induced Pluripotent Stem Cells Production market segments. Similarly, Strong end-user demand is encouraging Canadian Induced Pluripotent Stem Cells Production companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Induced Pluripotent Stem Cells Production market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Induced Pluripotent Stem Cells Production Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Induced Pluripotent Stem Cells Production industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Induced Pluripotent Stem Cells Production market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Induced Pluripotent Stem Cells Production Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Induced Pluripotent Stem Cells Production in Asia Pacific. In particular, China, India, and South East Asian Induced Pluripotent Stem Cells Production markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Induced Pluripotent Stem Cells Production Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Induced Pluripotent Stem Cells Production Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Induced Pluripotent Stem Cells Production market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Induced Pluripotent Stem Cells Production.
Induced Pluripotent Stem Cells Production Market Company Profiles
The global Induced Pluripotent Stem Cells Production market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Axol Bioscience Ltd, Cynata Therapeutics Ltd, Evotec SE, Fate Therapeutics Inc, FUJIFILM Cellular Dynamics Inc, LizarBio Therapeutics, Ncardia, REPROCELL USA Inc, Sumitomo Dainippon Pharma Co. Ltd, Takara Bio Inc, Thermo Fisher Scientific Inc, ViaCyte Inc
Recent Induced Pluripotent Stem Cells Production Market Developments
The global Induced Pluripotent Stem Cells Production market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Induced Pluripotent Stem Cells Production Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Process
Manual iPSC Production Process
Automated iPSC Production Process
By Workflow
Reprogramming
Cell Culture
Cell Characterization / Analysis
Engineering
Others
By Product
Instruments/ Devices
Automated Platforms
Consumables & Kits
-Media
-Kits
-Others
Services
By Application
Drug Development and Discovery
Regenerative Medicine
Toxicology Studies
Others
By End-User
Research & Academic Institutes
Biotechnology & Pharmaceutical Companies
Hospitals & Clinics
Geographical Segmentation:
Axol Bioscience Ltd
Cynata Therapeutics Ltd
Evotec SE
Fate Therapeutics Inc
FUJIFILM Cellular Dynamics Inc
LizarBio Therapeutics
Ncardia
REPROCELL USA Inc
Sumitomo Dainippon Pharma Co. Ltd
Takara Bio Inc
Thermo Fisher Scientific Inc
ViaCyte Inc
Formats Available: Excel, PDF, and PPT
The induced pluripotent stem cells production market is experiencing significant growth driven by the increasing demand for regenerative medicine and cell-based therapies, rising investment in stem cell research, and advancements in cellular reprogramming and differentiation techniques. In 2024 and beyond, factors such as the growing application of iPSCs in drug discovery, disease modeling, and tissue engineering, expansion of iPSC production facilities and biobanks, and rising adoption of automation and quality control measures drive market expansion. Additionally, the development of integration-free and xeno-free reprogramming methods, adoption of genome editing tools for genetic correction, and collaborations between stem cell companies and research institutions contribute to market growth.
Induced Pluripotent Stem Cells Production Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Induced Pluripotent Stem Cells Production market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Induced Pluripotent Stem Cells Production survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Induced Pluripotent Stem Cells Production industry.
Key market trends defining the global Induced Pluripotent Stem Cells Production demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Induced Pluripotent Stem Cells Production Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Induced Pluripotent Stem Cells Production industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Induced Pluripotent Stem Cells Production companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Induced Pluripotent Stem Cells Production industry
Leading Induced Pluripotent Stem Cells Production companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Induced Pluripotent Stem Cells Production companies.
Induced Pluripotent Stem Cells Production Market Study- Strategic Analysis Review
The Induced Pluripotent Stem Cells Production market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Induced Pluripotent Stem Cells Production industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Induced Pluripotent Stem Cells Production Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Induced Pluripotent Stem Cells Production Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Induced Pluripotent Stem Cells Production market segments. Similarly, Strong end-user demand is encouraging Canadian Induced Pluripotent Stem Cells Production companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Induced Pluripotent Stem Cells Production market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Induced Pluripotent Stem Cells Production Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Induced Pluripotent Stem Cells Production industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Induced Pluripotent Stem Cells Production market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Induced Pluripotent Stem Cells Production Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Induced Pluripotent Stem Cells Production in Asia Pacific. In particular, China, India, and South East Asian Induced Pluripotent Stem Cells Production markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Induced Pluripotent Stem Cells Production Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Induced Pluripotent Stem Cells Production Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Induced Pluripotent Stem Cells Production market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Induced Pluripotent Stem Cells Production.
Induced Pluripotent Stem Cells Production Market Company Profiles
The global Induced Pluripotent Stem Cells Production market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Axol Bioscience Ltd, Cynata Therapeutics Ltd, Evotec SE, Fate Therapeutics Inc, FUJIFILM Cellular Dynamics Inc, LizarBio Therapeutics, Ncardia, REPROCELL USA Inc, Sumitomo Dainippon Pharma Co. Ltd, Takara Bio Inc, Thermo Fisher Scientific Inc, ViaCyte Inc
Recent Induced Pluripotent Stem Cells Production Market Developments
The global Induced Pluripotent Stem Cells Production market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Induced Pluripotent Stem Cells Production Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Process
Manual iPSC Production Process
Automated iPSC Production Process
By Workflow
Reprogramming
Cell Culture
Cell Characterization / Analysis
Engineering
Others
By Product
Instruments/ Devices
Automated Platforms
Consumables & Kits
-Media
-Kits
-Others
Services
By Application
Drug Development and Discovery
Regenerative Medicine
Toxicology Studies
Others
By End-User
Research & Academic Institutes
Biotechnology & Pharmaceutical Companies
Hospitals & Clinics
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Axol Bioscience Ltd
Cynata Therapeutics Ltd
Evotec SE
Fate Therapeutics Inc
FUJIFILM Cellular Dynamics Inc
LizarBio Therapeutics
Ncardia
REPROCELL USA Inc
Sumitomo Dainippon Pharma Co. Ltd
Takara Bio Inc
Thermo Fisher Scientific Inc
ViaCyte Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Induced Pluripotent Stem Cells Production Market Overview and Key Findings, 2024
1.2 Induced Pluripotent Stem Cells Production Market Size and Growth Outlook, 2021- 2030
1.3 Induced Pluripotent Stem Cells Production Market Growth Opportunities to 2030
1.4 Key Induced Pluripotent Stem Cells Production Market Trends and Challenges
1.4.1 Induced Pluripotent Stem Cells Production Market Drivers and Trends
1.4.2 Induced Pluripotent Stem Cells Production Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Induced Pluripotent Stem Cells Production Companies
2. INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET SIZE OUTLOOK TO 2030
2.1 Induced Pluripotent Stem Cells Production Market Size Outlook, USD Million, 2021- 2030
2.2 Induced Pluripotent Stem Cells Production Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Process
Manual iPSC Production Process
Automated iPSC Production Process
By Workflow
Reprogramming
Cell Culture
Cell Characterization / Analysis
Engineering
Others
By Product
Instruments/ Devices
Automated Platforms
Consumables & Kits
-Media
-Kits
-Others
Services
By Application
Drug Development and Discovery
Regenerative Medicine
Toxicology Studies
Others
By End-User
Research & Academic Institutes
Biotechnology & Pharmaceutical Companies
Hospitals & Clinics
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Induced Pluripotent Stem Cells Production Market, 2025
5.2 Asia Pacific Induced Pluripotent Stem Cells Production Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Induced Pluripotent Stem Cells Production Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Induced Pluripotent Stem Cells Production Market, 2025
5.5 Europe Induced Pluripotent Stem Cells Production Market Size Outlook by Type, 2021- 2030
5.6 Europe Induced Pluripotent Stem Cells Production Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Induced Pluripotent Stem Cells Production Market, 2025
5.8 North America Induced Pluripotent Stem Cells Production Market Size Outlook by Type, 2021- 2030
5.9 North America Induced Pluripotent Stem Cells Production Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Induced Pluripotent Stem Cells Production Market, 2025
5.11 South America Pacific Induced Pluripotent Stem Cells Production Market Size Outlook by Type, 2021- 2030
5.12 South America Induced Pluripotent Stem Cells Production Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Induced Pluripotent Stem Cells Production Market, 2025
5.14 Middle East Africa Induced Pluripotent Stem Cells Production Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Induced Pluripotent Stem Cells Production Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Induced Pluripotent Stem Cells Production Market Size Outlook and Revenue Growth Forecasts
6.2 US Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
7. INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. INDUCED PLURIPOTENT STEM CELLS PRODUCTION COMPANY PROFILES
8.1 Profiles of Leading Induced Pluripotent Stem Cells Production Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Axol Bioscience Ltd
Cynata Therapeutics Ltd
Evotec SE
Fate Therapeutics Inc
FUJIFILM Cellular Dynamics Inc
LizarBio Therapeutics
Ncardia
REPROCELL USA Inc
Sumitomo Dainippon Pharma Co. Ltd
Takara Bio Inc
Thermo Fisher Scientific Inc
ViaCyte Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Induced Pluripotent Stem Cells Production Market Overview and Key Findings, 2024
1.2 Induced Pluripotent Stem Cells Production Market Size and Growth Outlook, 2021- 2030
1.3 Induced Pluripotent Stem Cells Production Market Growth Opportunities to 2030
1.4 Key Induced Pluripotent Stem Cells Production Market Trends and Challenges
1.4.1 Induced Pluripotent Stem Cells Production Market Drivers and Trends
1.4.2 Induced Pluripotent Stem Cells Production Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Induced Pluripotent Stem Cells Production Companies
2. INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET SIZE OUTLOOK TO 2030
2.1 Induced Pluripotent Stem Cells Production Market Size Outlook, USD Million, 2021- 2030
2.2 Induced Pluripotent Stem Cells Production Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Process
Manual iPSC Production Process
Automated iPSC Production Process
By Workflow
Reprogramming
Cell Culture
Cell Characterization / Analysis
Engineering
Others
By Product
Instruments/ Devices
Automated Platforms
Consumables & Kits
-Media
-Kits
-Others
Services
By Application
Drug Development and Discovery
Regenerative Medicine
Toxicology Studies
Others
By End-User
Research & Academic Institutes
Biotechnology & Pharmaceutical Companies
Hospitals & Clinics
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Induced Pluripotent Stem Cells Production Market, 2025
5.2 Asia Pacific Induced Pluripotent Stem Cells Production Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Induced Pluripotent Stem Cells Production Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Induced Pluripotent Stem Cells Production Market, 2025
5.5 Europe Induced Pluripotent Stem Cells Production Market Size Outlook by Type, 2021- 2030
5.6 Europe Induced Pluripotent Stem Cells Production Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Induced Pluripotent Stem Cells Production Market, 2025
5.8 North America Induced Pluripotent Stem Cells Production Market Size Outlook by Type, 2021- 2030
5.9 North America Induced Pluripotent Stem Cells Production Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Induced Pluripotent Stem Cells Production Market, 2025
5.11 South America Pacific Induced Pluripotent Stem Cells Production Market Size Outlook by Type, 2021- 2030
5.12 South America Induced Pluripotent Stem Cells Production Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Induced Pluripotent Stem Cells Production Market, 2025
5.14 Middle East Africa Induced Pluripotent Stem Cells Production Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Induced Pluripotent Stem Cells Production Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Induced Pluripotent Stem Cells Production Market Size Outlook and Revenue Growth Forecasts
6.2 US Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Induced Pluripotent Stem Cells Production Industry Drivers and Opportunities
7. INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. INDUCED PLURIPOTENT STEM CELLS PRODUCTION COMPANY PROFILES
8.1 Profiles of Leading Induced Pluripotent Stem Cells Production Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Axol Bioscience Ltd
Cynata Therapeutics Ltd
Evotec SE
Fate Therapeutics Inc
FUJIFILM Cellular Dynamics Inc
LizarBio Therapeutics
Ncardia
REPROCELL USA Inc
Sumitomo Dainippon Pharma Co. Ltd
Takara Bio Inc
Thermo Fisher Scientific Inc
ViaCyte Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
